HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials-Reference-Cited by-同舟云学术

HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR , FOCUS and PICCOLO colorectal cancer trials

Published:2016-01-29 Issue:4 Volume:238 Page:562-570
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Richman Susan D¹,Southward Katie¹,Chambers Philip¹,Cross Debra²,Barrett Jennifer³,Hemmings Gemma¹,Taylor Morag¹,Wood Henry¹,Hutchins Gordon¹,Foster Joseph M⁴,Oumie Assa⁴,Spink Karen G⁴,Brown Sarah R⁵,Jones Marc⁵,Kerr David⁶,Handley Kelly⁷,Gray Richard⁸,Seymour Matthew⁹,Quirke Philip¹

Affiliation:

1. Section of Pathology and Tumour Biology Leeds Institute of Cancer and Pathology, University of Leeds UK

2. Histopathology and Molecular Pathology St James University Hospital Leeds UK

3. Section of Epidemiology and Biostatistics Leeds Institute of Cancer and Pathology, University of Leeds UK

4. Affymetrix UK Ltd High Wycombe UK

5. Clinical Trials Research Unit University of Leeds Leeds UK

6. Cancer Medicine University of Oxford UK

7. Birmingham Clinical Trials Unit University of Birmingham UK

8. Clinical Trials Service Unit and Epidemiology Studies Unit University of Oxford UK

9. Section of Oncology Leeds Institute of Cancer and Pathology, University of Leeds UK

Funder

Yorkshire Cancer Research